deltatrials
Unknown OBSERVATIONAL NCT04669990

Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study

Sponsor: Nepal Health Research Council

Conditions Covid19
Interventions Remdesivir
Updated 5 times since 2021 Last updated: Dec 15, 2020 Started: Nov 19, 2020 Primary completion: Oct 31, 2021 Completion: Nov 19, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Covid19, this trial is ongoing. The trial is conducted by Nepal Health Research Council and has accumulated 5 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2021 – ~Jan 2023 · 24 months · monthly snapshotRecruiting~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  4. Jan 2023 — Jul 2024 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  5. Jan 2021 — Jan 2023 [monthly]

    Recruiting

    First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Nepal Health Research Council
Data source: Nepal Health Research Council

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations